Small airway hyperresponsiveness in COPD: relationship between structure and function in lung slices by Maarsingh, Harm et al.
RESEARCH ARTICLE
Small airway hyperresponsiveness in COPD: relationship between structure
and function in lung slices
Harm Maarsingh,1,2,7,8 Cécile M. Bidan,3,4 Bindi S. Brook,5 Annet B. Zuidhof,1,7,8
Carolina R.S. Elzinga,1,7,8 Marieke Smit,1,6,7 Anouk Oldenburger,1,7,8 Reinoud Gosens,1,7,8 Wim Timens,6,7
and Herman Meurs1,7,8
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands; 2Department of
Pharmaceutical Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida;
3Laboratoire Interdisciplinaire de Physique, Centre for Scientific Research, Université Grenoble Alpes, Grenoble, France;
4Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany; 5School of Mathematical
Sciences, University of Nottingham, Nottingham, United Kingdom; 6Department of Pathology and Medical Biology, University
Medical Center Groningen, Groningen, The Netherlands; 7Groningen Research Institute of Asthma and Chronic Obstructive
Pulmonary Disease, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and
8Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
Submitted 19 July 2018; accepted in final form 30 December 2018
Maarsingh H, Bidan CM, Brook BS, Zuidhof AB, Elzinga CR,
Smit M, Oldenburger A, Gosens R, Timens W, Meurs H. Small
airway hyperresponsiveness in COPD: relationship between structure
and function in lung slices. Am J Physiol Lung Cell Mol Physiol 316:
L537–L546, 2019. First published January 10, 2019; doi:10.1152/
ajplung.00325.2018.—The direct relationship between pulmonary
structural changes and airway hyperresponsiveness (AHR) in chronic
obstructive pulmonary disease (COPD) is unclear. We investigated
AHR in relation to airway and parenchymal structural changes in a
guinea pig model of COPD and in COPD patients. Precision-cut lung
slices (PCLS) were prepared from guinea pigs challenged with lipo-
polysaccharide or saline two times weekly for 12 wk. Peripheral
PCLS were obtained from patients with mild to moderate COPD and
non-COPD controls. AHR to methacholine was measured in large and
small airways using video-assisted microscopy. Airway smooth mus-
cle mass and alveolar airspace size were determined in the same
slices. A mathematical model was used to identify potential changes
in biomechanical properties underlying AHR. In guinea pigs, lipo-
polysaccharide increased the sensitivity of large (150 m) airways
toward methacholine by 4.4-fold and the maximal constriction of
small airways (150 m) by 1.5-fold. Similarly increased small
airway responsiveness was found in COPD patients. In both lipopo-
lysaccharide-challenged guinea pigs and patients, airway smooth
muscle mass was unaltered, whereas increased alveolar airspace
correlated with small airway hyperresponsiveness in guinea pigs.
Fitting the parameters of the model indicated that COPD weakens
matrix mechanical properties and enhances stiffness differences be-
tween the airway and the parenchyma, in both species. In conclusion,
this study demonstrates small airway hyperresponsiveness in PCLS
from COPD patients. These changes may be related to reduced
parenchymal retraction forces and biomechanical changes in the
airway wall. PCLS from lipopolysaccharide-exposed guinea pigs may
be useful to study mechanisms of small airway hyperresponsiveness
in COPD.
airway constriction; airway remodeling; biomechanical modeling;
emphysema; human lung
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a chronic
inflammatory disease, characterized by a progressive and par-
tially irreversible decline in lung function and by airway
hyperresponsiveness (AHR) (13, 14, 23, 24). Chronic inflam-
mation in COPD causes structural alterations and narrowing of
particularly the small airways, and emphysema, characterized
by parenchymal destruction. It has been proposed that loss of
lung function and AHR may result from small airway remod-
eling, including increased airway smooth muscle (ASM) mass,
and from loss of elastic recoil by parenchymal damage (13, 14,
23, 24). These structural changes may differ between patients,
depending on various factors (13).
Although this hypothesis has been around for several de-
cades, evidence for a direct relationship between structural
changes in the lung and small airway function is still lacking.
Measurement of airway mechanics in precision-cut lung slices
(PCLS) using video-assisted microscopy ex vivo (19, 26) may
be highly instrumental in investigating the impact of structural
changes on airway responsiveness. Microscopic visualization
allows performance of these studies even in the smallest
airways, a major breakthrough for the study of small airway
function.
Limited studies on small airway mechanics in PCLS from
animal models of COPD are known (5, 7, 8, 16, 17, 33). In one
of these studies, enhanced small airway responsiveness to
carbachol and serotonin was found in rats after chronic in vivo
exposure to tobacco smoke, which was associated with in-
creased airway wall -smooth muscle actin (-SMA) content
(5). In contrast, no small airway hyperresponsiveness was
observed in mice after short-term exposure to cigarette smoke
(8), elastase (17), or lipopolysaccharide (LPS) (7). However,
exposure of mouse PCLS to elastase or collagenase ex vivo
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induced AHR to acetylcholine and methacholine (16, 17, 33).
Mechanical studies in PCLS from patients with COPD have
thus far not been described.
In this study, we investigated alterations in the responsive-
ness of large and small intrapulmonary airways to methacho-
line in PCLS obtained from a guinea pig model of COPD
induced by chronic LPS exposure (22). This model resembles
COPD patho(physio)logy in several ways: the presence of
neutrophilic inflammation, mucus hypersecretion, emphysema,
small airway fibrosis, and vascular remodeling (22). In addi-
tion, guinea pig lungs contain both large and small airways. We
also determined the relationship between structural compo-
nents of the airways and parenchyma (ASM mass and paren-
chymal integrity) and responsiveness of the individual airways
within the same PCLS. Importantly, this relationship was also
assessed for small airways in lung slices obtained from human
control subjects and patients with mild to moderate COPD.
Finally, we used a multiscale model of an airway embedded in
parenchyma (12) to identify possible alterations in biomechani-
cal properties that could underlie the observations in PCLS.
METHODS
Animals. Outbred male specified pathogen-free Dunkin Hartley
guinea pigs (Harlan, Heathfield, UK) weighing 350–400 g were used.
The animals were housed in pairs under a 12-h:12-h light-dark cycle
in a temperature- and humidity-controlled room with food and tap
water ad libitum. All animal care and experimental procedures com-
plied with the animal protection and welfare guidelines, were ap-
proved by the Institutional Animal Care and Use Committee of the
University of Groningen, The Netherlands, and are reported in com-
pliance with the ARRIVE guidelines (18).
Lipopolysaccharide instillation. At the start of the protocol, guinea
pigs were randomly selected to be challenged by intranasal instillation
of 200 l LPS (5 mg/ml in sterile saline; Sigma-Aldrich, St. Louis,
MO) or 200 l sterile saline (control group) two times weekly for 12
consecutive weeks as described by Pera et al. (22). To this aim,
conscious guinea pigs were held in an upright position while the LPS
solution was slowly instilled. After the intranasally instilled solution
was aspirated, the animals were kept in the upright position for an
additional 2 min to allow sufficient spreading of the fluid throughout
the airways. Animal welfare was monitored by weighing the animals
before each intranasal instillation; no animals needed to be withdrawn
from the protocol. Previous studies have demonstrated that guinea
pigs challenged with LPS are a good model for COPD, since it
induces various inflammatory and pathological changes closely mim-
icking COPD (22, 32).
Guinea pig lung slices. After the last challenge (24 h), precision-cut
lung slices were prepared as described previously (20, 25). The
animals were euthanized using an overdose of pentobarbital sodium
(Euthasol 20%; Produlab Pharma, Raamsdonkveer, The Netherlands)
followed by exsanguination via the aorta abdominalis. The trachea
was cannulated, the diaphragm was opened, and the lungs were filled
through the cannula at constant pressure with a low-melting-point
agarose (Gerbu Biotechnik, Weiblingen, Germany) solution (1.5%) in
a buffer containing (in mM) 0.9 CaCl2, 0.4 MgSO4, 2.7 KCl, 58.2
NaCl, 0.6 NaH2PO4, 8.4 glucose, 13 NaHCO3, 12.6 HEPES, 0.5
sodium pyruvate, 1 glutamine, minimal essential medium (MEM)-
amino acids mixture (1:50), and MEM-vitamins mixture (1:100),
pH  7.2. The agarose solution contained 1 M isoproterenol to
prevent postmortem constriction (25). After filling, the lungs were
covered with ice for at least 30 min to solidify the agarose for slicing.
The lungs were removed, and cylindrical tissue cores were prepared
from the lobes using a rotating sharpened metal tube (diameter 15
mm), followed by slicing the tissue in ice-cold buffer composed of 1.8
mM CaCl2, 0.8 mM MgSO4, 5.4 mM KCl, 116.4 mM NaCl, 1.2 mM
NaH2PO4, 16.7 mM glucose, 26.1 mM NaHCO3, 25.2 mM HEPES,
and 1 M isoproterenol, pH  7.2, using a tissue slicer (Compress-
tome VF- 300 microtome; Precisionary Instruments, San Jose, CA).
Lung slices were cut at a thickness of 500 m and washed several
times to remove the agarose and cell debris from the tissue. Slices
were incubated in a 12-well plate overnight in MEM composed of (in
mM) 1.8 CaCl2, 0.8 MgSO4, 5.4 KCl, 116.4 NaCl, 1.2 NaH2PO4, 16.7
glucose, 26.1 NaHCO3, 25.2 HEPES, 0.5 sodium pyruvate, 1 glu-
tamine, MEM-amino acids mixture (1:50), and MEM-vitamins mix-
ture (1:100), pH  7.2, containing penicillin and streptomycin (1:
100), at 37°C in a CO2- and humidity-controlled atmosphere.
Human lung slices. Peripheral lung tissue from COPD GOLD 1
(n  4) and GOLD 2 (n  3) patients and from non-COPD control
subjects (n  5) was obtained from subjects undergoing surgery for
lung cancer using tumor-free tissue far from the tumor site, except one
control that was obtained from a nontransplanted donor lung. All
tissue was collected according to the Research Code of the University
Medical Center Groningen (https://www.umcg.nl/SiteCollectionDocuments/
English/Researchcode/UMCG-Researchcode,%20basic%20principles%
202013.pdf) and national ethical and professional guidelines (“Code of
conduct,” Dutch Federation of Biomedical Scientific Societies, https://
www.federa.org). Characteristics of the subjects are shown in Table 1.
After placing on a metal plate on ice, 2% low-melting agarose was
slowly injected in the tissue, evenly distributed at several sites of the
tissue, essentially as described by Sturton et al. (29). Subsequently,
the tissue was covered with ice for 15 min. Cylindrical cores of 15 mm
in diameter were prepared, cut with a tissue slicer into 500 m thin
slices, and processed as described above for guinea pig lung slices.
Airway responsiveness measurements. After the slices were washed
in medium, airway responsiveness to methacholine (109 to 3  103
M, using cumulative concentrations in half-log increments) was as-
sessed in 1–6 slices/animal or human donor, using video-assisted
microscopy (Nikon Eclipse TS 100). To this aim, individual slices
were positioned under the microscope using a 24-well plate, mechan-
ically maintained with a Teflon ring of 7 mm inner diameter and 10
mm outer diameter, and covered with 1 ml of MEM. The only slices
used were those with approximately circular airways (longest/shortest
diameter  2) and with ciliary beating as an indication of intact
epithelium and viability of the slices. In guinea pig slices, methacho-
line-induced contraction was measured both in large and small air-
ways (in this species defined by diameters larger and smaller than 150
m, respectively), whereas, in human slices, only small airways
(500 m) were studied. To quantify airway luminal area, image
acquisition software (NIS-Elements; Nikon) was used. Images of the
airways were acquired every 2 s during the whole course of the
experiment, starting 2 min before the addition of the first dose of
contracting agent to allow for baseline measurements of the airway
caliber. Airway constriction was then expressed as percentage of the
Table 1. Clinical data
Control Subjects COPD Patients
No. of subjects 5* 7
Age, yr† 65 (42–69) 66 (42–69)
Men/women† 2/2 5/2
Ex/current smoker† 3/1 4/3
Pack-years†§ 40 (28–52) 50 (20–54)
FEV1, %predicted† 109.5 (87–122) 89 (58–115)
FEV1/FVC† 74.2 (69.4–84.2) 60.1 (52.5–67.3)
Values, except no. of subjects, sex, and smoking status, are medians
(ranges). COPD, chronic obstructive pulmonary disease; FEV1, forced expi-
ratory volume in 1 s; FVC, forced vital capacity. *4 non-COPD patients
undergoing surgery for lung cancer and 1 healthy lung donor. †Data for healthy
lung donor not available. §Data from 2 control subjects and 2 COPD patients
are missing.
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initial (baseline) area of the airway lumen. Per slice, one airway was
measured. After the cumulative concentration-response curve was
established, slices were thoroughly washed in fresh medium.
Histochemistry. After a subsequent overnight washout, lung slices
were placed in cassettes supported by biopsy foam pads, fixed in 10%
formalin for 24 h, and embedded in paraffin. Paraffin sections (4 m
thin) were cut from the slices to assess remodeling parameters.
Airway smooth muscle mass was determined by -SMA staining.
After deparaffinization, endogenous peroxidase was blocked for 30
min using 0.3% H2O2 in PBS [(in mM)140 NaCl, 2.6 KCl, 1.4
KH2PO4, and 8.1 Na2HPO4, pH7.4). After 5 min washing with PBS,
the sections were cooked in 10 mM Na3-citrate buffer, pH 6, for 5 min
using a pressure cooker. Sections were then incubated for 15 min with
1% Triton X-100 in PBS and washed three times with PBS afterward.
The sections were incubated for 2 min with mouse anti--smooth
muscle actin antibody (Sigma-Aldrich), diluted 1:1,000 in 1% bovine
serum albumin (BSA) in PBS. Subsequently, the sections were incu-
bated for 30 min with 1% BSA in PBS and washed three times with
PBS. The secondary antibody [horseradish peroxidase-conjugated
goat anti-mouse IgG antibody (Sigma-Aldrich), 1:200 in 1% BSA in
PBS] was incubated for 30 min and washed three times with PBS.
3,3=-Diaminobenzidine (DAB) was dissolved in PBS at a concentra-
tion of 0.34 mg/ml, and 0.3% H2O2 was added just before use. After
20 min incubation, sections were washed with ultrapure water and
counterstained with hematoxylin. After 5 min rinsing under running
tap water, sections were dehydrated in ethanol and covered with
mounting medium. Airways were digitally photographed and ana-
lyzed using Image J software (National Institutes of Health, Bethesda,
MD). The positively stained area (m2) was normalized to the square
of the basement membrane length (m2). For evaluation of emphy-
sema, paraffin sections were stained with hematoxylin and eosin.
Mean linear intercept (MLI) was determined as a measure of alveolar
airspace size as described previously (22), using 20–25 photomicro-
scopic images (magnification, 200) per slice.
Mathematical model. A multiscale biomechanical model previously
developed (12) was used to couple contractile force generated by airway
smooth muscle at the cell level and the narrowing of a nonlinearly elastic
airway wall embedded in parenchyma. Briefly, this model considers the
airway as an axisymmetric thick-walled cylinder of fixed length in a
plane-strain approximation (with no axial displacement) and consists of
two layers representing the airway wall and the surrounding parenchymal
tissue. The parenchyma is assumed to be a compressible linear elastic
material with compressibility 	, which can be reduced to mimic connec-
tive tissue damage associated with COPD. The airway wall is considered
to be an incompressible nonlinear elastic material of modulus represented
by the variable 
when parametrized relative to the elastic modulus of the
parenchyma at zero stress. As such, an increase in 
 may be interpreted
as an increase of airway elasticity modulated by matrix structure and/
or a degradation of elastin in the parenchyma. The finite thickness  of
the airway wall is normalized by the radius of the lumen. Fibers embed-
ded as rings in the airway wall represent the ASM bundles and the
collagen-dominated extracellular matrix; they are thus assumed to pas-
sively stiffen as collagen is recruited upon airway inflation (uncrimping
of collagen fibers and thus increased load bearing) and to actively
generate a contractile force upon ASM activation. The passive stiffness of
these fibers is governed by two parameters C1 and C2: C1 takes into
account the density of fibers, whereas C2 governs the nonlinear increase
in the stiffness of the fibers as they stretch. The active contribution of the
ASM in the mechanical properties of the airway results from cellular
forces generated by contractile units made of a myosin filament and
adjacent actin filaments.  is a parameter accounting for the volume
fraction of the ASM cells in the airway, the number of parallel myosin
filaments within a single ASM cell and also indirectly for the density of
receptors within an ASM cell. Multiplying  by the contractile force
generated by a single myosin filament determined via the Huxley-Hai-
Murphy (HHM) model results in the overall contractile force of the ASM.
Note that a fixed prestress is also applied to mimic the inflation of the
lung in the preparation of the PCLS. Additionally, displacement and
radial stress are assumed to be always continuous at the boundary
between the airway wall and the parenchyma.
First, simulations using this model were used to generate con-
centration-response curves and identify a baseline set of parame-
ters fitting the concentration-response curves from the human and
guinea pig control data. Further simulations were then carried out
to determine the changes required in the six parameters above to
generate similar changes to those observed in the dose-response
curves of human COPD- and LPS-challenged guinea pig PCLS.
The parameter changes identified in this way enable inference of
the structural changes that could have occurred to generate the
observations. The MATLAB scripts for running model simulations
as described here can be obtained by contacting the corresponding
author of Hiorns et al. (12).
Data analysis. Data are expressed as means  SE. An n  1
represents the average of the measurements of each airway classifi-
cation per animal. A power analysis (1–2  40,   30,   0.5,
power  0.8) determined that nine animals were to be included per
group for the constriction experiments. Per group, 10 animals were
included to anticipate an experimental dropout rate of 10%, which
allowed for housing all guinea pigs in pairs. Statistical differences
were determined by two-way ANOVA, by paired or unpaired Stu-
dent’s t-test, or by Mann-Whitney U-test as appropriate. Correlations
were determined using Pearson’s correlation coefficient test. Differ-
ences were considered statistically significant when P  0.05.
RESULTS
Airway responsiveness in guinea pigs. Methacholine in-
duced a concentration-dependent constriction of intrapulmo-
nary large and small airways in PCLS obtained from saline-
and LPS-challenged guinea pigs (Fig. 1, A and B). Interest-
ingly, the maximal constriction (Emax) of the large airways
from the saline-challenged controls was 1.8-fold higher com-
pared with that of small airways of the same animals (P 
0.001), without a difference in sensitivity (pD2) toward meth-
acholine (Table 2). In the large airways of PCLS from LPS-
challenged animals, a 4.4-fold higher sensitivity toward meth-
acholine was observed compared with large airways from
saline-challenged controls (P  0.01), with a small increase in
maximal effect (P  0.05; Fig. 1A and Table 2). The maximal
constriction of small airways from LPS-challenged animals
was 1.5-fold higher compared with saline-challenged controls
(P  0.001), without a difference in sensitivity toward meth-
acholine (Fig. 1B and Table 2). Airway sizes among saline- and
LPS-challenged guinea pigs, respectively, were similar for
large (265  16 vs. 264  15 m) and small (112  5 vs.
111  4 m).
ASM mass and alveolar airspace size in guinea pigs. Com-
pared with saline-challenged controls, repeated LPS challenge
did not alter ASM mass of either large or small airways as
determined by -SMA-positive area (Fig. 2A). Consequently,
no correlations between Emax or pD2 and ASM mass were
observed (Fig. 2B).
Repeated LPS challenge did induce a trend toward an
increase in MLI compared with saline-challenged animals
(P  0.10, Fig. 2C). Interestingly, a significant correlation
between MLI and Emax of small, but not large, airways was
found (Fig. 2D). No correlations between MLI and pD2 values
were observed (Fig. 2D).
Small airway responsiveness in human PCLS. The respon-
siveness of human peripheral control airways to methacholine
(Fig. 3 and Table 2) was similar to that in the small airways
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from saline-challenged guinea pigs (Fig. 1B and Table 2). A
1.5-fold higher maximal constriction (P  0.05) was observed
in lung slices obtained from patients with COPD compared
with control subjects, without a difference in pD2 (Fig. 3 and
Table 2). There was no difference between the airway diame-
ters of control subjects (273  59 m) and COPD patients
(227  48 m). Remarkably, the hyperresponsiveness of the
COPD airways was identical to that observed in the small
airways of the LPS-challenged guinea pigs.
ASM mass and alveolar airspace size in human PCLS. No
difference in ASM mass was found between slices from control
subjects and subjects with COPD (Fig. 4A). A 1.2-fold higher
MLI was measured in the lung slices of the COPD patients
compared with the control subjects (P  0.05, Fig. 4C). There
were no significant correlations between the -SMA-positive
area (Fig. 4B) or the MLI (Fig. 4D) and the Emax/pD2 of
methacholine-induced airway constriction.
Changes in biomechanical properties in PCLS from COPD
patients and LPS-challenged guinea pigs. In the model, the
biomechanical properties of the airway wall (ASM and colla-
gen fibers) and parenchyma are characterized by the parame-
ters listed in Fig. 5A and Table 3 (12). Any structural changes
in the airway or parenchyma would modify these parameters
and impact the mechanical response to agonist challenge.
Baseline values of these parameters were first obtained by
fitting a simulated concentration-contraction curve to the ex-
perimental concentration-contraction one from human control
subjects (Fig. 5B and Table 3). The effect of changing one
parameter at a time was then explored. Similar baseline airway
diameters and ASM mass measured between control and
COPD slices justified keeping the airway wall thickness ()
and ASM density and/or muscarinic receptor density () at
baseline values for all human data simulations. Simulating
reduction in collagen fiber density within the airway wall (C1)
or in the extent to which they are recruited (C2) generated
minimal hyperresponsiveness (Fig. 5B). Similarly, reducing
the compressibility (	) or the stiffness (increased 
) of the
parenchyma relative to the airway wall generated small levels
of hyperresponsiveness (Fig. 5B). Mimicking structural
changes to the collagen matrix within the airway wall without
changes to the parenchyma, and vice versa, thus had a limited
impact. In contrast, all of these parametric changes imple-
mented simultaneously induced a significant shift in the sim-
ulated dose-response curve, which matched the experimental
data obtained on COPD slices (Fig. 5B and Table 3). This
suggests that structural changes to the matrix occurring in
COPD (2) affect both the airway wall and the parenchyma,
modifying the effective mechanical properties of both com-
partments.
For guinea pig slices, model baseline parameters were first
fitted to the saline-challenged concentration-response curve for
small airways (Fig. 5C and Table 3). Higher ASM/muscarinic
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Fig. 1. Airway responsiveness toward methacholine (MCh) of large (A) and small (B) intrapulmonary airways in lung slices obtained from male guinea pigs challenged
with either saline or lipopolysaccharide (LPS), two times weekly for 12 wk. Data represent means SE of 8–9 animals/group. ***P  0.001 between curves.
Table 2. Airway responsiveness to methacholine of intrapulmonary large and small airways in lung slices obtained from
saline- and LPS-challenged guinea pigs and of intrapulmonary small airways in lung slices obtained from control subjects
and COPD patients
Group
Large Airways Small Airways
Emax, %constriction pD2, log M Emax, %constriction pD2, log M
Guinea pig
Saline challenged 89.7  4.5 5.83  0.12 48.6  5.4††† 5.52  0.25
LPS challenged 98.3  1.0* 6.47  0.17** 72.7  3.9***††† 5.88  0.26†
Human
Control subjects 45.8  11.1 5.68  0.37
COPD patients 67.9  3.2# 5.77  0.18
Values are means  SE of 8–9 guinea pigs/group, 5 control subjects, and 7 chronic obstructive pulmonary disease (COPD) patients. Emax, maximal effect;
pD2, log of the concentration causing 50% effect (log EC50); LPS, lipopolysaccharide. *P  0.05, **P  0.01, and ***P  0.001 compared with
saline-challenged guinea pigs. †P  0.05 and †††P  0.001 compared with corresponding large airways. #P  0.05 compared with control subjects.
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receptor density () and nonzero inflation pressure were required
to fit the guinea pig data. Changes in both airway wall and
parenchymal properties were needed to match the LPS-challenged
guinea pig experimental concentration-response curve for small
airways. Specifically, a slightly thicker airway was needed (pa-
rameter set 1 or 2), together with reduced collagen fiber density
and parenchymal compressibility and stiffness relative to the
baseline guinea pig parameters (Fig. 5C and Table 3). In the case
of the saline-treated guinea pig data for large airways, simulated
dose-response curves fitted to the experimental dose-response
curve (Fig. 5D and Table 3) suggested that slightly thicker
airways () and significantly increased ASM/muscarinic receptor
density () are present. The biomechanical model was unable to
generate dose-response curves for the LPS-treated guinea pig data
for the large airways.
DISCUSSION
This study successfully shows the high potential of guinea
pig and human PCLS in studying (small) airway mechanics in
relation to tissue remodeling in COPD. Both in PCLS from a
guinea pig model of LPS-induced COPD and in PCLS from
patients with mild to moderate COPD, we demonstrated small
airway hyperresponsiveness to methacholine, which is not
Fig. 2. A: -smooth muscle actin (-SMA)-positive area of large and small airways in lung slices obtained from male guinea pigs challenged with either saline
or lipopolysaccharide (LPS), two times weekly for 12 wk. Representative images are shown for each group and airway classification (A, airway; V, vessel). The
bar indicates 500 m for the large airways and 200 m for the small airways. B: correlations between airway smooth muscle mass (-SMA-positive area) and
airway responsiveness [top, difference in sensitivity (pD2); bottom, maximal constriction (Emax)] of large and small airways. BM, basement membrane. Data
represent means  SE of 7–10 animals/group. ***P  0.001 compared with large airways. C: effects of repeated saline or LPS challenge on alveolar airspace
size [mean linear intercept (MLI)] in male guinea pig lung slices obtained from guinea pigs challenged with either saline or LPS, two times weekly for 12 wk.
D: correlations between MLI and airway responsiveness (top, pD2; bottom, Emax) of large and small airways. Data represent means  SE of 8–10 animals/group.
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caused by increased ASM mass, but may be related to reduced
parenchymal stiffness and compressibility involving increased
alveolar airspace size and reduced stiffness of the passive
components of the airway wall.
In PCLS from LPS-challenged guinea pigs, a 1.5-fold in-
crease in maximal methacholine-induced airway constriction
was observed in the small airways, without a change in sensi-
tivity toward the agonist. Only a small increase in Emax was
observed in the large airways of LPS-challenged animals, due
to the pronounced (90%) methacholine-induced constriction of
these airways in the saline group. An increase in pD2 was
observed in large airways. Further studies indicated that em-
physema may be involved in LPS-induced small airway hy-
perresponsiveness, since increased alveolar airspace sizes were
positively correlated with the Emax in small airways within the
same PCLS. No correlation between these parameters was
found for the large airways; neither was there a correlation
between MLI and pD2 values for either airway type. From a
pharmacological point of view, these results indicate that
postreceptor changes are involved in the increased small air-
way constriction to methacholine, which may at least partially
be caused by structural changes in the parenchyma. Because
ASM mass was unaltered after LPS challenge for either airway
type and there was no correlation between ASM mass and
airway responsiveness, ASM mass per se is not an important
determinant of AHR in this model.
Remarkably, we found a larger maximal methacholine-
induced narrowing of the large airways compared with the
small airways, both after saline and LPS challenge. Studies in
rat PCLS demonstrated that airway responsiveness (reduction
in airway luminal area) toward electrical field stimulation is
greater in large airways compared with small airways (28),
whereas no differences in the responsiveness to methacholine
were observed (19). We did not observe significant differences
in sensitivity (pD2) toward methacholine between large and
small airways in PCLS obtained from saline-challenged guinea
pigs. However, in rats, the sensitivity to methacholine is
greater in the large airways than in the small airways (19),
whereas the opposite has been observed in mice (6). Because
different techniques were used in the latter study (6) to deter-
mine the constriction of trachea (contractility) and small air-
ways (airway area), the responsiveness (Emax) of large and
small airways cannot be compared. The increased responsive-
ness of the large airways in guinea pig PCLS is not related to
the ASM mass, since, similar to human airways (9), the relative
ASM thickness was smaller in the large airways. Previous
findings using the same animal model demonstrated that re-
peated LPS challenge did not alter the active tension of isolated
airways induced by either methacholine or histamine (T. Pera,
R. Gosens, A. Zuidhof, H. Maarsingh, J. Zaagsma, and H.
Meurs, unpublished observations), further supporting the con-
tribution of structural changes in the parenchyma to the ob-
served LPS-induced AHR.
This study also describes the first measurements of airway
mechanics in PCLS from COPD patients. Remarkably, PCLS
of human control subjects demonstrated a similar responsive-
ness of the peripheral airways to methacholine as the small
airways of saline-challenged guinea pigs. This confirms previ-
ous observations that guinea pig PCLS are an excellent phys-
iological and pharmacological model for human tissue (25, 27).
Similar to the guinea pig data, hyperresponsiveness to metha-
choline, characterized by an increased Emax, of peripheral
airways from patients with mild to moderate COPD (GOLD 1
and 2) was observed. In line with previous studies (13) and the
guinea pig model, no changes in ASM mass in the small
airways were observed in patients with mild to moderate
COPD. Slices from the COPD patients did reveal a small but
significantly enhanced MLI; however, no significant correla-
tion between MLI and Emax was observed. This may be
because of both the low number of subjects and the involve-
ment of additional factors, such as microstructural changes in
the extracellular matrix components, which may similarly
impact the mechanical behavior of the airways and the paren-
chyma (2).
In the alveolar and small airway walls of COPD patients,
reduced expression of elastin and decorin, a proteoglycan
involved in the assembly of collagen fibers, and increased
expression of collagen have been described (2, 11, 14, 34, 36).
Similar observations have been reported for smoke- and LPS-
induced guinea pig models of COPD characterized by small
airway remodeling and emphysema (4, 15, 22). Because the
mechanical properties of collagen fibers highly depend on the
quality of their assembly, higher collagen content does not
necessarily lead to a stiffer tissue (30). Thus, loss of decorin as
observed in COPD (14, 34, 36) will lead to disorganization and
sliding of collagen fibers despite an increase of the matrix
protein. Indeed, imaging revealed structural differences of
parenchymal collagen and elastin between nondiseased sub-
jects and COPD patients (1, 31). Moreover, PCLS studies in
mice showed disorganized and stretched parenchymal collagen
fibers upon elastin degradation (33). Consequences of extra-
cellular matrix changes for mechanical functions of the lung
have been explored in PCLS ex vivo and revealed that airway
responsiveness is enhanced upon protease-induced degradation
of elastin or collagen fibers (16, 33).
The emerging hypothesis of a central role of extracellular
matrix remodeling in AHR (2, 3, 30) is further supported by a
biomechanical model (12). The contribution on airway respon-
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Fig. 3. Airway responsiveness toward methacholine (MCh) of peripheral
airways in lung slices obtained from control subjects and from patients with
chronic obstructive pulmonary disease (COPD). Data represent means  SE of
5 control subjects and 7 COPD patients. **P  0.01 between curves.
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siveness of the active ASM cells and the passive airway and
parenchymal matrixes could be assessed separately by para-
metric changes. Simulations of the contraction experiments
could fit the COPD experimental data only when changes to
passive mechanical properties occurred in both the airway wall
and the parenchyma compared with control PCLS. The relative
weakening of the extracellular matrix in COPD suggested by
these changes, potentially including elastin degradation,
decorin loss, and disorganization of collagen fibers, is consis-
tent with both the observation of hyperresponsiveness despite
a conserved airway smooth muscle mass and with the increased
MLI in COPD patients and LPS-challenged guinea pigs.
Guinea pig has a thicker ASM layer compared with most
species, which could explain why the biomechanical model
could not generate concentration-contraction curves for the
LPS-treated guinea pig data for the large airways and would
potentially require distinct baseline characteristics. Indeed, the
model parameter fit suggests that, in the control data, both
airway wall thickness and ASM density needed to be greater
than the corresponding human parameters (Table 3). Another
explanation for the failure of the model to simulate the LPS-
treated guinea pig data for the large airways is a potentially
higher baseline tone that the model is not able to account for.
Additionally, any stretch-dependent changes in the parameters
(such as decreased tethering in response to strong contraction
as a result of LPS-modified extracellular matrix) are not ac-
counted for in the current model but could be an explanation
for the strong dose response.
Only few studies reported on small airway structure and
responsiveness in PCLS in animal models with characteristics
of COPD. Thus, cigarette smoke exposure of rats during 8–16
wk increased the sensitivity but not the Emax of intrapulmonary
Fig. 4. A: -smooth muscle actin (-SMA)-positive area in lung slices obtained from control subjects and chronic obstructive pulmonary disease (COPD) patients.
Representative images are shown for control (top) and COPD (bottom). Data represent means  SE of 5 control subjects and 6 COPD patients. B: alveolar
airspace size [mean linear intercept (MLI)] in lung slices of control subjects and COPD patients. Data represent means  SE of 5 control subjects and 7 COPD
patients. *P  0.05 compared with control. C: correlations between airway smooth muscle mass (-SMA-positive area) and airway responsiveness (top, pD2;
bottom, Emax). D: correlations between MLI and airway responsiveness (top, pD2; bottom, Emax).
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airways to carbachol and serotonin, and increased ASM mass,
which correlated with the sensitivity to serotonin, but not
carbachol (5). Although we did not find an increased ASM
mass in our model or in our patients with mild to moderate
COPD, the absence of a correlation between ASM mass and
hyperresponsiveness to the muscarinic agonist (5) corresponds
to our observations. No changes in sensitivity to serotonin or
methacholine were found after acute exposure of the rats to
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Fig. 5. A: schematic overview of our previously developed multiscale mathematical model (11) for which a given agonist concentration k1 (model input) causes
airway smooth muscle (ASM) cell shortening via actomyosin crossbridge interactions at the cell level, thereby generating airway narrowing at the tissue level.
This allows prediction of the lumen radius (r) at each concentration (k1) to generate dose-response curves for a given set of parameter values for airway and
parenchymal mechanical properties and cell properties listed above. Note that additional outputs are also generated by the model, such as radial and
circumferential tissue stresses () and contractile force at the cell level (A), but the most direct comparison with experimental data is via the lumen radius.
Multiple simulations were performed in which the parameters were varied within a range until a dose-response curve (k1 vs. r) is generated that best fits the
baseline/control experimental data. Once this fit (a set of baseline parameters) is obtained, the parameter values are varied one at a time to identify those factors
that contribute the most to the modified dose-response curves of the lipopolysaccharide (LPS)/chronic obstructive pulmonary disease (COPD) data. B: simulated
concentration-contraction curves (solid lines) for human control data and COPD data (from Fig. 3). Inflation pressure for these simulations was set as 0. In the
simulation, the effect of an increased 
, a reduced C1, a reduced C2, and a reduced v individually and the combination of all the parameters was tested
(“combination”). C: simulated dose-response curves (solid lines) for saline- and LPS-treated guinea pig slices for small airways with different wall thickness
parameters (parameter sets 1 and 2; experimental data from Fig. 1B). D: simulated dose-response curves (solid lines) for saline-treated guinea pig slices for large
airways (experimental data from Fig. 1A). Parameter values for the simulated curves are given in Table 3.
Table 3. Biomechanical parameters fitted to the experimental dose-response curves using the multiscale biomechanical
model of the airway embedded in parenchyma
Airways Wall Thickness
ASM Density/Muscarinic
Receptor Density
Collagen Fiber
Density
Strain Stiffening Because of
Collagen Recruitment
Compressibility of
Parenchyma
Elastic Modulus of Airway Wall
Relative to Parenchyma
Human
Control 0.3 5 0.25 1.0 0.4 5
COPD 0.3 5 0.05 0.14 0.1 100
Guinea pig
Small airway, saline 0.27 9 0.2 1.0 0.4 2
Small airway, LPS (set 1) 0.3 9 0.05 0.09 0.1 100
Small airway, LPS (set 2) 0.38 9 0.05 0.09 0.1 100
Large airway, saline 0.4 30 0.03 0.1 0.4 10
Note: parameters fitted to the guinea pig data required higher prestress (inflation pressure). ASM, airway smooth muscle; COPD, chronic obstructive
pulmonary disease; LPS, lipopolysaccharide.
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cigarette smoke (5), in line with a recent study on acute
cigarette smoke exposure in mice (8). In the latter study, a
change in the contraction pattern to serotonin, but not to
methacholine, was observed that was associated with a change
in ryanodine receptor expression (8). Although the acute mod-
els were characterized by cigarette smoke-induced inflamma-
tion, they are highly unlikely to demonstrate small airway
remodeling and emphysema that are important for AHR in
COPD. Similarly, airway hyperresponsiveness was not induced
in PCLS following acute exposure of mice to LPS, a proin-
flammatory contaminant from gram-negative bacteria in or-
ganic dusts and cigarette smoke that has been associated with
the development of COPD and bacterial infection-induced
exacerbations of COPD (10, 21, 22). However, chronic LPS
exposure induced COPD-like inflammation, small airway re-
modeling, and emphysema in mice and guinea pigs (22, 32,
35). The present study indicates that biomechanical changes
involved in small airway hyperresponsiveness in chronically
LPS-exposed guinea pigs translate to small airway hyperre-
sponsiveness in patients with COPD.
Regarding the 3Rs of the use of animals in biomedical
research (18), the current method of studying airway respon-
siveness in PCLS represents both refinement and reduction.
Airway responses of small and large airways to (multiple)
experimental drugs can be individually measured in different
PCLS from the same animal, thus lowering the number of
animals needed, whereas refinement is achieved by measuring
AHR ex vivo rather than in vivo. Moreover, linking mathe-
matical modeling with the functional studies may lead to future
reduction of animals needed to predict outcomes.
In conclusion, this is the first study demonstrating small
airway hyperresponsiveness in PCLS from patients with mild
to moderate COPD, which appears not to be caused by in-
creased airway smooth muscle mass but rather to be related to
reduced parenchymal retraction forces and reduced passive
stiffness of the airway wall. In addition, we found evidence that
PCLS from chronically LPS-exposed guinea pigs can serve as
a useful model to study mechanisms of small airway hyperre-
sponsiveness in mild and moderate COPD.
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